The global chimeric antigen receptor (CAR)-T cell therapy market size was valued at USD 2.72 billion in 2024 and is expected to reach USD 6.65 billion by 2032, at a CAGR of 11.80% during the forecast period The global business landscape is undergoing a transformation, with industries increasingly leaning on deep research and actionable insights to make strategic...